Head and neck cancer Cancer Malignant neoplasm of other and ill-defined sites: head, face and neck
Conditions
Interventions
Patients are randomised to receive study instruments in varying order of presentation.
There are no treatment arms or drugs used as it is a quality of life questionnaire study. The patients will be ap
Sponsors
University Hospitals Coventry & Warwickshire NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients 18 years old or over 2. Patients attending the thyroid or head neck cancer clinic who are: 2.1. Being treated or undergoing follow-up for differentiated (papillary or follicular) thyroid cancer or 2.2. Being investigated or treated for differentiated (papillary or follicular) thyroid cancer recurrence Note: patients with high grade variants such as insular carcinoma or poorly differentiated carcinoma are eligible 3. Male or female
Exclusion criteria
Exclusion criteria: 1. Patients who do not sufficiently understand the English language and those with learning disabilities ? as these are standardized and validated questionnaires which are in English 2. Patients who have medullary thyroid cancer or anaplastic thyroid cancer or lymphoma of the thyroid 3. Patients having a diagnostic hemithyroidectomy for possible thyroid cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient preference: identification of preferred quality of life instrument The study only comprises of one questionnaire pack (as explained above). This includes four different quality of life questionnaires that the patient will complete and then answer a set of evaluation questions at the end. Once we receive them back, they are entered on a spreadsheet and then sent to a statistician | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
United Kingdom
Outcome results
None listed